Works matching IS 14642662 AND DT 2010 AND VI 11 AND IP 10

Results: 17

Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya.

Published in:

2010

By:

Peters P;
Stringer J;
McConnell M;
Kiarie J;
Ratanasuwan W;
Intalapaporn P;
Potter D;
Mutsotso W;
Zulu I;
Borkowf C;
Bolu O;
Brooks J;
Weidle P

Publication type:

Journal Article

Defining high HIV incidence subgroups of Australian homosexual men: implications for conducting HIV prevention trials in low HIV prevalence settings.

Published in:

2010

By:

Poynten I;
Jin F;
Prestage G;
Kaldor J;
Kippax S;
Grulich A

Publication type:

Journal Article

'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients.

Published in:

2010

By:

Bourgeois N;
Bastien P;
Reynes J;
Makinson A;
Rouanet I;
Lachaud L

Publication type:

Journal Article

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients.

Published in:

2010

By:

Lambert-Niclot S;
Machouf N;
Peytavin G;
Soulie C;
Wirden M;
Simon A;
Murphy R;
Katlama C;
Thomas R;
Calvez V;
Marcelin A

Publication type:

Journal Article

HIV and pulmonary arterial hypertension: a systematic review.

Published in:

2010

By:

Janda S;
Quon B;
Swiston J

Publication type:

Journal Article

A screening algorithm for HIV-associated neurocognitive disorders.

Published in:

2010

By:

Cysique L;
Murray J;
Dunbar M;
Jeyakumar V;
Brew B

Publication type:

Journal Article

British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals.

Published in:

2010

By:

Gilleece Y;
Chadwick D;
Breuer J;
Hawkins D;
Smit E;
McCrae L;
Pillay D;
Smith N;
Anderson J

Publication type:

Journal Article

Defining high HIV incidence subgroups of Australian homosexual men: implications for conducting HIV prevention trials in low HIV prevalence settings IM Poynten et al. Identifying populations for prevention trials.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 635, doi. 10.1111/j.1468-1293.2010.00833.x

By:

Poynten, I. M.;
Jin, F.;
Prestage, G. P.;
Kaldor, J. M.;
Kippax, S.;
Grulich, A. E.

Publication type:

Article

Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa.

Published in:

2010

By:

Kharsany A;
Hancock N;
Frohlich J;
Humphries H;
Abdool Karim S;
Abdool Karim Q

Publication type:

Journal Article

Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya PJ Peters et al. Nevirapine-associated hepatotoxicity.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 650, doi. 10.1111/j.1468-1293.2010.00873.x

By:

Peters, P. J.;
Stringer, J.;
McConnell, M. S.;
Kiarie, J.;
Ratanasuwan, W.;
Intalapaporn, P.;
Potter, D.;
Mutsotso, W.;
Zulu, I.;
Borkowf, C. B.;
Bolu, O.;
Brooks, J. T.;
Weidle, P. J.

Publication type:

Article

A note of thanks to referees for Volume 11, 2010.

Published in:: HIV Medicine, 2010, v. 11, n. 10, p. 674, doi. 10.1111/j.1468-1293.2010.00894.x
Publication type:: Article

HIV and pulmonary arterial hypertension: a systematic review S Janda et al. HIV and pulmonary arterial hypertension.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 620, doi. 10.1111/j.1468-1293.2010.00829.x

By:

Janda, S.;
Quon, B. S.;
Swiston, J.

Publication type:

Article

'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients N Bourgeois et al. Active chronic visceral leishmaniasis.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 670, doi. 10.1111/j.1468-1293.2010.00846.x

By:

Bourgeois, N.;
Bastien, P.;
Reynes, J.;
Makinson, A.;
Rouanet, I.;
Lachaud, L.

Publication type:

Article

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients S Lambert-Niclot et al. Atazanavir inhibitory quotient in first-line therapy

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 666, doi. 10.1111/j.1468-1293.2010.00839.x

By:

Lambert-Niclot, S.;
Machouf, N.;
Peytavin, G.;
Soulie, C.;
Wirden, M.;
Simon, A.;
Murphy, R. L.;
Katlama, C.;
Thomas, R.;
Calvez, V.;
Marcelin, A.-G.

Publication type:

Article

A screening algorithm for HIV-associated neurocognitive disorders Cysique et al. NeuroAIDS algorithm.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 642, doi. 10.1111/j.1468-1293.2010.00834.x

By:

Cysique, L. A.;
Murray, J. M.;
Dunbar, M.;
Jeyakumar, V.;
Brew, B. J.

Publication type:

Article

British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010 Y Gilleece et al. British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 611, doi. 10.1111/j.1468-1293.2010.00889.x

By:

Gilleece, Y.;
Chadwick, D. R.;
Breuer, J.;
Hawkins, D.;
Smit, E.;
McCrae, L. X.;
Pillay, D.;
Smith, N.;
Anderson, J.

Publication type:

Article

Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa ABM Kharsany et al. Screening for acute HIV infection in pregnancy.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 661, doi. 10.1111/j.1468-1293.2010.00838.x

By:

Kharsany, A. B. M.;
Hancock, N.;
Frohlich, J. A.;
Humphries, H. R.;
Karim, S. S. Abdool;
Karim, Q. Abdool

Publication type:

Article